MAGNIS SURESELECT XT HS2 DNA XT DNA REAGENT KIT SURESELECT CANCER CGP ASSAY, RNA - INVIMA Registration 3d73c5540ab0a5eaa2240195fc212189
Access comprehensive regulatory information for MAGNIS SURESELECT XT HS2 DNA XT DNA REAGENT KIT SURESELECT CANCER CGP ASSAY, RNA (MAGNIS SURESELECT XT HS2 DNA XT DNA REAGENT KIT SURESELECT CANCER CGP ASSAY, RNA) in the Colombia medical device market through Pure Global AI's free database. This I medical device is registered under INVIMA analysis ID 3d73c5540ab0a5eaa2240195fc212189 and manufactured by GENCELL PHARMA SAS. The device was registered on March 01, 2034.
This page provides complete registration details including product type (REACTIVOS IN VITRO), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
SÓLO PARA USO EN INVESTIGACIÓN._x000D_ 4. MAGNIS SURESELECT XT HS2 DNA REAGENT KIT _x000D_ SURESELECT CANCER CGP ASSAY, RNA: EL PROCESO PARA _x000D_ EL ENRIQUECIMIENTO DE OBJETIVOS DE ADN SURESELECT_x000D_ XT HS2 KIT SURESELECT CANCER CGP ASSAY, RNA_x000D_ UTILIZANDO EL SISTEMA MAGNIS NGS PREP SYSTEM _x000D_ REQUIERE QUE LAS MUESTRAS DE ADN, LOS REACTIVOS _x000D_ PRESEMBRADOS Y EL MATERIAL DE LABORATORIO SEAN _x000D_ CARGADOS EN EL EQUIPO. UNA VEZ CARGADOS, EL _x000D_ SISTEMA MAGNIS NGS PREP SYSTEM LLEVA A CABO TODOS _x000D_ LOS PASOS NECESARIOS PARA LA PREPARACIÓN DE LA _x000D_ BIBLIOTECA DE ADN SURESELECT XT HS2 Y LA _x000D_ MANIPULACIÓN DEL LÍQUIDO DE ENRIQUECIMIENTO DE _x000D_ OBJETIVOS. TRAS LA FINALIZACIÓN DEL PROCESO CON EL _x000D_ SISTEMA MAGNIS NGS PREP SYSTEM, LAS BIBLIOTECAS _x000D_ CON LOS OBJETIVOS DE ADN ENRIQUECIDOS ESTÁN LISTAS_x000D_ PARA SER COMBINADAS EN LA PREPARACIÓN DE MUESTRAS_x000D_ NGS MULTIPLEXADAS Y PARA EL ANÁLISIS DE_x000D_ SECUENCIAS MEDIANTE EL USO DE SECUENCIADORES _x000D_ ILLUMINA. EL ENSAYO SURESELECT CANCER CGP OFRECE _x000D_ UN PERFIL GENÓMICO COMPLETO PARA TUMORES SÓLIDOS._x000D_ ESTE PANEL DE NGS PAN-CÁNCER PERMITE LA DETECCIÓN _x000D_ DE VARIANTES SOMÁTICAS, INCLUYENDO VARIANTES DE _x000D_ NUCLEÓTIDO ÚNICO (SNVS), VARIANTES DE NÚMERO DE COPIA (CNVS), INSERCIONES/DELECIONES (INDELS), TRANSLOCACIONES (TLS), FUSIONES GÉNICAS, Y LOS BIOMARCADORES DE INMUNOONCOLOGÍA TMB (CARGA MUTACIONAL TUMORAL) Y MSI_x000D_ (INESTABILIDAD DE MICROSATÉLITES).
FOR USE IN INVESTIGACIÓN._x000D_ ONLY 4. MAGNIS SURESELECT XT HS2 DNA REAGENT KIT _x000D_ SURESELECT CANCER CGP ASSAY, RNA: THE PROCESS TO _x000D_ DNA Target Enrichment SURESELECT_x000D_ XT HS2 SURESELECT CANCER CGP ASSAY KIT, RNA_x000D_ USING THE MAGNIS NGS PREP SYSTEM _x000D_ IT REQUIRES DNA SAMPLES, REAGENTS, _x000D_ PRE-SEEDED AND LABORATORY EQUIPMENT ARE _x000D_ LOADED INTO THE EQUIPMENT. ONCE CHARGED, THE _x000D_ MAGNIS NGS PREP SYSTEM PERFORMS ALL _x000D_ THE STEPS NECESSARY FOR THE PREPARATION OF THE _x000D_ SURESELECT XT HS2 DNA LIBRARY AND THE _x000D_ HANDLING _x000D_ ENRICHMENT LIQUID OBJECTIVES. AFTER THE COMPLETION OF THE PROCESS WITH THE _x000D_ MAGNIS NGS PREP SYSTEM, _x000D_ LIBRARIES WITH ENRICHED DNA TARGETS THEY ARE LISTAS_x000D_ TO BE COMBINED IN THE PREPARATION OF MUESTRAS_x000D_ MULTIPLEXED NGS AND FOR DE_x000D_ ANALYSIS SEQUENCES USING SEQUENCERS _x000D_ ILLUMINA. THE SURESELECT CANCER CGP ASSAY OFFERS _x000D_ A COMPLETE GENOMIC PROFILE FOR SÓLIDOS._x000D_ TUMORS THIS PAN-CANCER NGS PANEL ALLOWS FOR THE DETECTION _x000D_ OF SOMATIC VARIANTS, INCLUDING VARIANTS OF _x000D_ SINGLE NUCLEOTIDE (SNVS), COPY NUMBER VARIANTS (CNVS), INSERTIONS/DELETIONS (INDELS), TRANSLOCATIONS (TLS), GENE FUSIONS, AND IMMUNO-ONCOLOGY BIOMARKERS TMB (TUMOR MUTATIONAL BURDEN) AND MSI_x000D_ (INSTABILITY OF MICROSATELLITES).